Ningping Feng
0000-0003-1917-9648
Publication & Citation Trends
Publications
0 total
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types OA
Cited by 4
Semantic Scholar
Abstract A24: Targeting mitochondrial metabolism following Induction Chemotherapy eradicates Acute Myeloid Leukemia at the level of Minimal Residual Disease
Cited by 0
Semantic Scholar
Abstract 4017: TAS2940 inhibits intracranial tumor growth and prolongs survival in HER2-aberrant and EGFR-amplified patient-derived xenograft models
Cited by 0
Semantic Scholar
Oncogenic KrasG12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8+ T cells dependent manner OA
Cited by 10
Semantic Scholar
Abstract 92: Deploying spatial transcriptomics to inform intratumoral heterogeneity in late-stage uveal melanoma leveraging advanced preclinical modeling and clinical samples
Cited by 0
Semantic Scholar
Abstract 94: Advanced preclinical modeling reveals unique monosomy 3 associated biology in late-stage uveal melanoma
Cited by 0
Semantic Scholar
SMARCB1 regulates the hypoxic stress response in sickle cell trait OA
Cited by 22
Semantic Scholar
Ether phospholipids are required for mitochondrial reactive oxygen species homeostasis OA
Cited by 36
Semantic Scholar
Research Topics
PARP inhibition in cancer therapy
(34)
Cancer, Hypoxia, and Metabolism
(29)
Ovarian cancer diagnosis and treatment
(18)
Chromatin Remodeling and Cancer
(18)
Biochemical and Molecular Research
(17)
Affiliations
Roche (Switzerland)
Meridian Institute
United States Department of Health and Human Services
National Institutes of Health
The University of Texas MD Anderson Cancer Center